Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter ended September 30, 2010.

29 Oct 2010

Teck donates $2.5M to support emergency programs and services at St. Paul's Hospital

St. Paul's Hospital Foundation today announced that Teck Resources Limited donated $2.5 million to St. Paul's Hospital to complete the remaining funding for its recently renovated and redesigned emergency area. In recognition of Teck's major gift, the area will be named the Teck Emergency Centre. Furthermore, a fund to support research, academic productivity and the development of best practices at the hospital will be called the Teck Emergency Centre Innovation Fund.

28 Oct 2010

Higher heart rate linked to shorter life expectancy

If you are a person who already has stable heart disease, how fast your heart beats at rest can predict your risk of dying, not only from heart disease but all other causes, Dr. Eva Lonn told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

27 Oct 2010

CJPS Medical releases VitalPoint device to improve healthcare

CJPS Medical Systems releases VitalPoint this week, a medical device capable of measuring patients' vital signs from home, while allowing direct communication with their caregiver, and generating and saving HIPAA-compliant electronic medical records.

27 Oct 2010

Telehealth Monitoring System improves health outcomes in patients with chronic diseases

Patients with Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF), Diabetes, and wounds are often treated and stabilized in a hospital setting then discharged to continue care at home under the supervision of a Certified Home Health Care Agency. Many high risk patients can now be monitored at home through a Telehealth Monitoring System.

27 Oct 2010

miRagen and CU enter agreement on miRNA therapeutics discovery and development

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and the University of Colorado (CU) announced today that they have entered into sponsored research and licensing agreements to collaborate on miRNA therapeutics discovery and development.

26 Oct 2010

New heart and vascular clinic to implement Streamline Health's HIM Suite of document workflow solutions

Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that one of the country's leading healthcare organizations expects to open a new facility utilizing Streamline Health's Suite of Health Information Management document workflow solutions.

26 Oct 2010

High erythropoietin levels predict higher mortality

High erythropoietin levels in people over age 85 indicate a higher risk of death, according to a study published in CMAJ.

26 Oct 2010

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Summaries of a number of new Canadian Cardiovascular Society guidelines and position statements offering the most up to date information to support clinicians in practicing evidence-based medicine were released at the Canadian Cardiovascular Congress 2010 this week.

25 Oct 2010

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Levels of anxiety sensitivity may be important in choosing medical treatment for patients with heart failure and atrial fibrillation (AF), Montreal Heart Institute researchers today told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.

25 Oct 2010

Scientists find two proteins that regulates water retention in salt-sensitive hypertension

Research conducted by scientists at LSU Health Sciences Center New Orleans has found that two proteins in the brain act as valves to turn the hormone that regulates water retention in the body on and off. Their findings may lead to advances in treatment for diseases like high blood pressure, congestive heart failure, and cirrhosis of the liver. The research is published in the November 1, 2010 issue of Endocrinology.

25 Oct 2010

72% of patients misdiagnosed with pneumonia upon readmission : Study

Patients were misdiagnosed with pneumonia at an alarming rate when they were readmitted to the hospital shortly after a previous hospitalization for the same illness, according to two Henry Ford Hospital companion studies.

25 Oct 2010

Astellas suspends patient enrollment from ACT 5 study of KYNAPID

Cardiome Pharma Corp. today announced that its co-development partner, Astellas Pharma US., Inc., has suspended patient enrollment in the ACT 5 study of KYNAPIDTM (vernakalant hydrochloride) Injection following a single unexpected serious adverse event of cardiogenic shock experienced by a patient with atrial fibrillation who received KYNAPID.

22 Oct 2010

Biomarkers can improve ability to identify patients at high risk of CKD: Study

Measuring three biomarkers in a single blood sample may improve physicians' ability to identify patients at high risk of developing chronic kidney disease, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology.

22 Oct 2010

Regulus present advancements in microRNA platform at Oligonucleotide Therapeutics Society meeting

Regulus Therapeutics Inc. announced today that advancements from its leading microRNA platform and product pipeline were presented at the "6th Annual Meeting of the Oligonucleotide Therapeutics Society" held October 20 - 23, 2010 in Dana Point, California.

22 Oct 2010

Astellas suspends enrollment in ACT 5 study of KYNAPID in atrial fibrillation patients

21 Oct 2010

PolyMedix plans PMX-60056 Phase 2 clinical trial in interventional cardiology

PolyMedix, Inc., a biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has announced plans for a Phase 2 clinical trial of PMX-60056 in interventional cardiology, and the establishment of a focused Heptagonist Clinical Advisory Board (CAB). PMX-60056 is a synthetic small-molecule designed to reverse the anticoagulant activity of heparin and low molecular weight heparins (LMWH).

21 Oct 2010

Beaumont Hospital announces opening of new Ernst Cardiovascular Center

Beaumont Hospitals' world renowned heart center has expanded and enhanced its services with the Oct. 18 opening of the new Ernst Cardiovascular Center at Beaumont Hospital, Royal Oak.

21 Oct 2010

FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer

Genentech, a member of the Roche Group today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin (trastuzumab) in combination with chemotherapy (cisplatin plus either capecitabine or 5-fluorouracil [5-FU]) for HER2-positive metastatic (cancer that has spread) cancer of the stomach or gastroesophageal junction, in men and women who have not received prior medicines for their metastatic disease.

21 Oct 2010

Beryl Institute awards $1,000 grants to health care organizations

As part of its commitment to supporting efforts to improve the patient experience in healthcare, The Beryl Institute has awarded $1,000 grants to ten health care organizations that are exploring effective methods for addressing patient experience issues.

20 Oct 2010

Heart Failure News and Research

Further Reading

Neurocrine third quarter revenue increases from $0.7 million to $14.4 million

Teck donates $2.5M to support emergency programs and services at St. Paul's Hospital

Higher heart rate linked to shorter life expectancy

CJPS Medical releases VitalPoint device to improve healthcare

Telehealth Monitoring System improves health outcomes in patients with chronic diseases

miRagen and CU enter agreement on miRNA therapeutics discovery and development

New heart and vascular clinic to implement Streamline Health's HIM Suite of document workflow solutions

High erythropoietin levels predict higher mortality

New Canadian Cardiovascular Society guidelines support clinicians in practicing evidence-based medicine

Anxiety sensitivity levels may help in choosing medical treatment for AF patients

Scientists find two proteins that regulates water retention in salt-sensitive hypertension

72% of patients misdiagnosed with pneumonia upon readmission : Study

Astellas suspends patient enrollment from ACT 5 study of KYNAPID

Biomarkers can improve ability to identify patients at high risk of CKD: Study

Regulus present advancements in microRNA platform at Oligonucleotide Therapeutics Society meeting

Astellas suspends enrollment in ACT 5 study of KYNAPID in atrial fibrillation patients

PolyMedix plans PMX-60056 Phase 2 clinical trial in interventional cardiology

Beaumont Hospital announces opening of new Ernst Cardiovascular Center

FDA approves Herceptin with chemotherapy for HER2-positive metastatic cancer

Beryl Institute awards $1,000 grants to health care organizations

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News